Endovascular interventions for TransAtlantic InterSociety Consensus II C and D femoropopliteal lesions
Min-yi Yin1, Mi-er Jiang, Xin-tian Huang
1Department of Vascular Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University, Shanghai 200011, China.
Insights
Endovascular treatment for severe femoropopliteal artery disease (TASC II C/D) shows high success and good patency rates. Key factors for restenosis include hyperlipidemia, lesion length, and popliteal artery involvement.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Interventions
Background:
- Peripheral artery disease (PAD) causes significant morbidity and hospitalizations.
- Endovascular techniques offer an aggressive approach to PAD treatment.
- TASC II C and D lesions represent complex femoropopliteal occlusive disease.
Purpose of the Study:
- To evaluate outcomes of endovascular interventions for TASC II C and D femoropopliteal occlusive disease.
- To determine technical success, complication rates, and patency.
- To identify predictors of restenosis/occlusion.
Main Methods:
- Retrospective review of patients undergoing endovascular intervention for femoropopliteal occlusive disease (2007-2010).
- Data collected: demographics, risk factors, ABI, technical success, complications.
- Patency assessed by Kaplan-Meier analysis; univariate/multivariate analyses for predictors.
Main Results:
- 91.1% technical success rate; 12.0% complication rate (5.1% major).
- Primary patency at 1 year: 95% (TASC II C) vs. 89% (TASC II D).
- Secondary patency at 4 years: 94% (TASC II C) vs. 83% (TASC II D). Hyperlipidemia, lesion length, popliteal involvement predicted restenosis.
Conclusions:
- Endovascular treatment of TASC II C/D femoropopliteal disease achieves high technical success.
- Favorable mid-term secondary patency rates were observed.
- Hyperlipidemia, lesion length, and popliteal artery involvement are independent risk factors for in-stent restenosis.
Background:
Peripheral artery disease accounts for more than 400 000 hospitalizations in the USA and results in symptoms ranging from claudication to gangrene. Recent advances in endovascular techniques have led to a more aggressive approach for treating peripheral artery disease. The aim of this retrospective study was to evaluate the outcomes of endovascular interventions on TransAtlantic InterSociety Consensus (TASC) II C and D femoropopliteal occlusive disease.
Methods:
Data for all patients undergoing endovascular interventions for femoropopliteal occlusive disease from December 2007 through December 2010 were reviewed. Demographic data, risk factor data, preprocedural and postprocedural ankle-brachial indices, technical success rates, and complication rates were obtained. Primary, assisted primary, and secondary patency were determined by Kaplan-Meier survival analysis. Univariate and multivariate analyses were performed to identify factors adversely affecting primary patency.
Results:
The study group included 52 TASC II C and 106 TASC II D limbs in 126 patients (mean age, (68.0 ± 18.0) years). The technical success rate was 91.1%. Complications occurred in 19 limbs (12.0%), including 8 (5.1%) major complications. The mean follow-up period was (17.6 ± 5.1) months (range, 12.0 - 48.0 months). Primary patency rates at 1, 2, 3, and 4 years were 95%, 78%, 74%, and 74% in TASC II C lesions and 89%, 62%, 52%, and 52% in TASC II D lesions, respectively. Secondary patency rates at 1, 2, 3, and 4 years were 97%, 94%, 94%, and 94% in TASC II C lesions and 97%, 95%, 83%, and 83% in TASC II D lesions, respectively. It is significantly different between primary patency rates (P < 0.05) but not secondary patency rates of TASC II C and D groups (P > 0.05). Predictors of restenosis/occlusion included hyperlipidemia, lesion length, and popliteal artery involvement.
Conclusions:
Endovascular treatment of TASC II C and D femoropopliteal artery occlusion has a high technical success rate with favorable mid-term secondary patency rate. Hyperlipidemia, lesion length, and popliteal artery involvement were independent risk factors for in-stent restenosis.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
